Carolina Conte

Carolina Conte

Auto-generated profile, based on publicly available information

Carolina Conte

Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
MMMaria Elena Melica
Maria Elena Melica
GAGiulia Antonelli
Giulia Antonelli
RSRoberto Semeraro
Roberto Semeraro
MAMaria Lucia Angelotti
Maria Lucia Angelotti
GLGianmarco Lugli
Gianmarco Lugli
PRPaola Romagnani
Paola Romagnani
Crescentic glomerulonephritis is characterized by vascular necrosis and parietal epithelial cell hyperplasia in the space surrounding the glomerulus, resulting in the formation of crescents. Little is known about the molecular mechanisms driving this process. Inducing crescentic glomerulonephritis in two Pax2Cre reporter mouse models revealed that crescents derive from clonal expansion of single immature parietal epithelial cells. Preemptive and delayed histone deacetylase inhibition with panobinostat, a drug used to treat hematopoietic stem cell disorders, attenuated crescentic glomerulonephritis with recovery of kidney function in the two mouse models. Three-dimensional confocal microscopy and stimulated emission depletion superresolution imaging of mouse glomeruli showed that, in addition to exerting an anti-inflammatory and immunosuppressive effect, panobinostat induced differentiation of an immature hyperplastic parietal epithelial cell subset into podocytes, thereby restoring the glomerular filtration barrier. Single-cell RNA sequencing of human renal progenitor cells in vitro identified an immature stratifin-positive cell subset and revealed that expansion of this stratifin-expressing progenitor cell subset was associated with a poor outcome in human crescentic glomerulonephritis. Treatment of human parietal epithelial cells in vitro with panobinostat attenuated stratifin expression in renal progenitor cells, reduced their proliferation, and promoted their differentiation into podocytes. These results offer mechanistic insights into the formation of glomerular crescents and demonstrate that selective targeting of renal progenitor cells can attenuate crescent formation and the deterioration of kidney function in crescentic glomerulonephritis in mice.

30 January 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
VRValentina Raglianti
Valentina Raglianti
MAMaria Lucia Angelotti
Maria Lucia Angelotti
LCLetizia De Chiara
Letizia De Chiara
MAMarco Allinovi
Marco Allinovi
LCLuigi Cirillo
Luigi Cirillo
PRPaola Romagnani
Paola Romagnani
An abstract is unavailable. This article is available as a PDF only.

2 April 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
MMMaria Elena Melica
Maria Elena Melica
GAGiulia Antonelli
Giulia Antonelli
Roberto SemeraroRoberto Semeraro
Roberto Semeraro
GRGilda La Regina
Gilda La Regina
TDTommaso Dafichi
Tommaso Dafichi
Laura LasagniLaura Lasagni
Laura Lasagni
Key Points: Piezo1 regulates perinuclear actin remodeling, and its loss induces nuclear envelope defects and accumulation of DNA damage. Piezo1 loss in podocytes leads to mitotic catastrophe. Podocyte-specific and podocyte progenitor–specific knockout of Piezo1 in mice result in severe albuminuria after adriamycin nephropathy. Background: Podocytes and podocyte progenitors are interdependent components of the kidney's glomerular structure, with podocytes forming the glomerular filtration barrier and progenitors being key players in podocyte regeneration during pathophysiologic processes. Both cell types are subjected to constant mechanical forces, whose alterations can initiate podocytopathy and worsen glomerular injury. Despite this, the specific mechanosensors and mechanotransduction pathways involved in their response to mechanical cues remain only partially explored. Methods: We used transcriptomics, immunofluorescence, and silencing experiments on human primary podocyte progenitor cell cultures to demonstrate the expression and function of Piezo1 channels. We generated inducible podocyte-specific and podocyte progenitor–specific Piezo1 knockout (KO) mice to evaluate the effects of Piezo1 loss in the context of adriamycin nephropathy and over 10 months of aging. Results: Silencing of Piezo1 in progenitors triggered F-actin remodeling, which induced cell shape modification and nuclear envelope defects with accumulation of DNA damage that led to mitotic catastrophe in differentiated podocytes. Podocyte-specific KO of Piezo1 induced higher susceptibility to podocyte injury in adriamycin nephropathy and led to accumulation of DNA damage and mild albuminuria starting from adult age. Podocyte progenitor–specific KO of Piezo1 in mouse resulted in severe albuminuria during adriamycin nephropathy, leading to the generation of defective podocytes. Conclusions: These results demonstrated that Piezo1, thanks to its role in F-actin cytoskeleton maintenance, is essential for the survival of podocytes exposed to mechanical stress conditions and for their correct regeneration.

4 September 2025 in Science
Verified
Journal Article
Closed access
CCCarolina Conte
Carolina Conte
MAMaria Lucia Angelotti
Maria Lucia Angelotti
BMBenedetta Mazzinghi
Benedetta Mazzinghi
MMMaria Elena Melica
Maria Elena Melica
GAGiulia Antonelli
Giulia Antonelli
PRPaola Romagnani
Paola Romagnani
The global burden of kidney disease displays marked sexual dimorphism. Lineage tracing and single-cell RNA-sequencing revealed that starting from puberty, estrogen signaling in female mice supports self-renewal and differentiation of renal progenitors to increase filtration capacity, reducing sensitivity to glomerular injury compared with that of males. This phenomenon accelerated as female kidneys adapted to the workload of pregnancy. Deletion of estrogen receptor α in renal progenitors disrupted this adaptation, leading to preeclampsia, fetal growth restriction, and increased maternal risk of hypertension and chronic kidney disease. Offspring from affected mothers had fewer nephrons, resulting in early-life hypertension and greater susceptibility to kidney disease. These results highlight the fundamental role of kidney fitness and renal progenitors for pregnancy and preeclampsia and as a determinant of sexual dimorphism in kidney disease.

23 July 2026 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
VRValentina Raglianti
Valentina Raglianti
MAMaria Lucia Angelotti
Maria Lucia Angelotti
LCLuigi Cirillo
Luigi Cirillo
FBFrancesca Becherucci
Francesca Becherucci
LCLetizia De Chiara
Letizia De Chiara
PRPaola Romagnani
Paola Romagnani
Key Points: Anti–slit autoantibody profiles identified different podocytopathy phenotypes, with anti-podocin/KIRREL1 associated with FSGS and steroid resistance. Anti-nephrin, anti-podocin, and anti-KIRREL1 testing improved risk stratification, identifying patients at a risk of CKD and post-transplant recurrence. Background: Anti-nephrin, anti-podocin, and anti-KIRREL1 antibodies are increasingly recognized as causes of autoimmune podocytopathies, yet autoantibody-specific clinical phenotypes remain poorly defined. Methods: We conducted a multicenter study integrating serology and super-resolution microscopy in 471 samples, including 213 cases with 146 kidney biopsies (minimal change n =63, FSGS n =83), and sera from 128 patients (minimal changes n =30, FSGS n =42, idiopathic nephrotic syndrome or isolated proteinuria n =56), including 61 paired specimens plus 258 controls (75 kidney biopsies, 200 sera, including 17 paired specimens). Paired specimens were used to assess ELISA performance by comparing serum results with IgG colocalization of target proteins within the filtration slit using receiver operating characteristic curves. All assays showed high specificity but lower sensitivity than super-resolution microscopy. Clinical features and long-term outcomes associated with individual autoantibodies and their combinations were also evaluated. Results: Anti–slit diaphragm antibodies were detected in 67/213 patients: 63% had anti-nephrin, 9% anti-podocin, or 3% anti-KIRREL1 antibodies only, while 25% had multiple autoantibodies. Isolated anti-nephrin antibodies were associated with minimal changes (91%), steroid sensitivity (88%), and absence of CKD over 120 months. In contrast, anti-podocin and/or anti-KIRREL1 antibodies correlated with FSGS (84%), steroid resistance (58%), CKD progression (36%), and kidney failure (24%). Among 26 transplant recipients with FSGS, early post-transplant recurrence occurred in 83% of autoantibodies carriers and in 5% of the others. Recurrent patients showed anti-podocin/KIRREL1 antibodies, with or without anti-nephrin. Conclusions: These findings suggest that anti-podocin and anti-KIRREL1 antibodies associate with steroid resistance, FSGS, and disease recurrence after transplantation in autoimmune podocytopathies.

19 May 2026 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
AVAnne Høy Seemann Vestergaard
Anne Høy Seemann Vestergaard
HSHelene Matilde Lundsgaard Svane
Helene Matilde Lundsgaard Svane
SJSimon Kok Jensen
Simon Kok Jensen
UHUffe Heide-Jørgensen
Uffe Heide-Jørgensen
CCCarolina Conte
Carolina Conte
CCChristian Fynbo Christiansen
Christian Fynbo Christiansen
Objective: To examine the association between urinary protein excretion (UPE) level in preeclampsia and long‐term risk of maternal hypertension, chronic kidney disease (CKD), and cardiovascular disease (CVD). Design: Nationwide, population‐based cohort study utilising routinely collected individual‐level data from medical databases. Setting: Denmark, 1998–2018, with follow‐up through 2021. Population: All pregnancies ≥ 20 weeks among women aged ≥ 15 years. Methods: We calculated cumulative incidences (risks) of hypertension, CKD, and CVD by preeclampsia status, including UPE level (no/mild versus moderate/severe, based on established urine protein/albumin cutoffs). Adjusted risk differences and risk ratios were computed for women with preeclampsia compared with those without, adjusting for age, smoking, obesity, residential region, and year. Main Outcome Measures: 10‐year risk, adjusted risk difference, and risk ratio of hypertension, CKD and CVD by preeclampsia status and UPE level. Results: Among 286 078 pregnant women, 9538 (3.3%) developed preeclampsia, which was associated with higher risks of later hypertension, CKD or CVD. Among women with preeclampsia with no/mild UPE, 10‐year risks were 11.9% (95% CI: 10.9–13.0) for hypertension, 1.2% (95% CI: 0.9–1.6) for CKD and 1.1% (95% CI: 0.8–1.5) for CVD. With moderate/severe UPE, 10‐year risks were 16.0% (95% CI: 14.6–17.5) for hypertension, 5.1% (95% CI: 4.3–5.9) for CKD and 1.2% (95% CI: 0.8–1.7) for CVD. For hypertension and CVD, adjusted risk differences and risk ratios were similar across UPE levels, whereas CKD risk increased with higher UPE. Conclusion: Preeclampsia is associated with increased long‐term maternal risk of hypertension, CKD, and CVD. Higher UPE levels correlate with higher risk of later hypertension and CKD.